TrialStem cells translational medicine2020

First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline.

Alexander Averyanov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.